Back to search

Italy· 015228012

NOZINAN*20 cpr rivestite 25 mg

A levomepromazine product containing levomepromazina, registered in Italy by NEURAXPHARM ITALY SpA, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC N05AA02

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedNOZINAN*20 cpr rivestite 25 mgATCN05AA02REGISTER NO.015228012PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Levomepromazine is registered in 16 of 19 countries.

Countries holding a registration under ATC N05AA02 (levomepromazine), each read from that country’s own register.

  • This record: Italy
  • 8 of them publish a price we can compare per daily dose

Levomepromazine · ATC N05AA02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levomepromazine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $1.30 in Italy to $6.20 in Switzerland — a ×4.8 gap.

  • Italy: $1.30 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Levomepromazine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$6.20
  • IT Italy$1.30
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Active substance
Levomepromazina
Manufacturer
NEURAXPHARM ITALY SpA
Country
Italy (IT)
ATC code
N05AA02
ATC class
Levomepromazine
Defined daily dose
0.3 g, O
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    015228012
    NOZINAN*20 cpr rivestite 25 mg
    EUR 2.58

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

349 interactions on record for levomepromazine.

Graded by severity as the source publishes them — 44 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levomepromazine · interactions on record

349 records

  • 44 severe
  • 263 moderate
  • 8 minor

Most severe, free to view

  • MetoclopramideA03FA01severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe

34 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levomepromazine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levomepromazine products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Nozinan
  • Belgium · Nozinan
  • Czechia · Tisercin
  • Germany · Levomepromazin Aspire, Levomepromazin Neuraxpharm
  • Denmark · Levomepromazine Aspire
  • Estonia · Levomepromazine Orion
  • Spain · Sinogan
  • Finland · Levomepromazine Aspire, Levomepromazine Orion
  • France · Nozinan
  • United Kingdom (Northern Ireland) · Levomepromazine Hydrochloride Wockhardt Uk, Levomepromazine Maleate Morningside Healthcare
  • Greece · Nozinan
  • Croatia · Nozinan
  • Hungary · Tisercin
  • Ireland · Nozinan
  • Lithuania · Tisercin
  • Luxembourg · Nozinan
  • Latvia · Tisercin
  • Netherlands · Nozinan
  • Norway · Levomepromazine Aspire, Levomepromazine Orion
  • Poland · Levomentis, Tisercin
  • Portugal · Nozinan
  • Romania · Levomepromazin Aspire, Levomepromazin Terapia
  • Sweden · Levomepromazine Aspire, Levomepromazine Orion
  • Slovakia · Tisercin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3ac5d597-81c6-49d2-ba4d-de46e72e9193
GET /v1/drugs/3ac5d597-81c6-49d2-ba4d-de46e72e9193?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 2.58,
  "source": "aifa",
  "currency": "EUR",
  "strength": "LEVOMEPROMAZINA 25MG 20 UNITA' USO ORALE",
  "substance": "Levomepromazina",
  "equivalence_group": "O0B",
  "transparency_flag": null
}

See everything about levomepromazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.